TY  - GEN
AU  - Nibu,Ken-Ichi
AU  - Hayashi,Ryuichi
AU  - Asakage,Takahiro
AU  - Ojiri,Hiroya
AU  - Kimata,Yoshihiro
AU  - Kodaira,Takeshi
AU  - Nagao,Toshitaka
AU  - Nakashima,Torahiko
AU  - Fujii,Takashi
AU  - Fujii,Hirofumi
AU  - Homma,Akihiro
AU  - Matsuura,Kazuto
AU  - Monden,Nobuya
AU  - Beppu,Takeshi
AU  - Hanai,Nobuhiro
AU  - Kirita,Tadaaki
AU  - Kamei,Yuzuru
AU  - Otsuki,Naoki
AU  - Kiyota,Naomi
AU  - Zenda,Sadamoto
AU  - Omura,Ken
AU  - Omori,Koichi
AU  - Akimoto,Tetsuo
AU  - Kawabata,Kazuyoshi
AU  - Kishimoto,Seiji
AU  - Kitano,Hiroya
AU  - Tohnai,Iwai
AU  - Nakatsuka,Takashi
TI  - Japanese Clinical Practice Guideline for Head and Neck Cancer
SN  - 1879-1476
PY  - 2018///0321
KW  - Humans
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Carcinoma, Squamous Cell
KW  - therapy
KW  - Cetuximab
KW  - Chemoradiotherapy
KW  - methods
KW  - Head and Neck Neoplasms
KW  - Japan
KW  - Neck Dissection
KW  - Otorhinolaryngologic Surgical Procedures
KW  - Radiotherapy
KW  - Squamous Cell Carcinoma of Head and Neck
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1016/j.anl.2017.02.004
ER  -